Deriglidole is primarily used in research settings to study its effects on dopamine and serotonin receptors. It is often employed in pharmacological studies to understand its potential antipsychotic properties and its role in modulating neurotransmitter systems. Researchers utilize it to explore its impact on behaviors related to dopamine dysregulation, such as those seen in schizophrenia or other psychiatric disorders. Additionally, it is investigated for its potential to influence mood and cognitive functions, providing insights into the development of novel therapeutic agents. Its application is largely confined to experimental and preclinical studies, contributing to advancements in neuropharmacology.